Literature DB >> 21990315

Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.

Longyan Yang1, Ying Wang, Peng Chen, Jia Hu, Ying Xiong, Duiping Feng, Hua Liu, Hong Zhang, Hui Yang, Junqi He.   

Abstract

Expression of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) can be induced by estrogens at the posttranscriptional level. However, the molecular mechanism of the process is unclear. In this study, we found that the C terminus (CT) of PTEN is indispensable for 17-β-estradiol (E2)-increased PTEN expression. Therefore, we screened for PTEN-CT-associated proteins using a glutathione-S-transferase pull-down approach in combination with mass spectrometry-based proteomic analyses. Our experiments led to the identification of Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) as a major PTEN-CT binding partner. The first postsynaptic density protein-95/Discslarge/zonula occludens-1 homology domain of NHERF1 and the last four amino acids of PTEN were found to be key determinants of this interaction. By associating with PTEN, NHERF1 could enhance PTEN protein expression by retention of PTEN turnover, as demonstrated by NHERF1 overexpression and small interfering RNA-mediated knockdown experiments, respectively. Furthermore, NHERF1 inhibited ubiquitination of the PTEN protein upon competition with binding of PTEN to neural precursor cell expressed, developmentally down-regulated 4, an ubiquitin E3 ligase. E2 strongly induced the expression of NHERF1 and PTEN only in estrogen receptor (ER)-positive cells but not in ER-negative cells. ICI182780, an ER-specific inhibitor, decreased the expression of both NHERF1 and PTEN, and ICI182780 pretreatment also retarded E2-increased PTEN expression in ER-MDA-MB-231 cells. In both ER-MDA-MB-231 and MCF-7 cells, E2 failed to increase PTEN expression when NHERF1 was knocked down. Taken together, these are the first results that present a possible mechanism for E2-increased PTEN expression. In this process, E2 first induces NHERF1 expression by activating the ER. Upon competition with neural precursor cell expressed, developmentally down-regulated 4, NHERF1 then interacts with PTEN to inhibit PTEN degradation, through an ubiquitination-dependent pathway. This in turn leads to the increase of PTEN expression at the protein level.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990315     DOI: 10.1210/en.2011-1207

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells.

Authors:  Hong Liu; Yan Ma; Hong-Wei He; Jia-Ping Wang; Jian-Dong Jiang; Rong-Guang Shao
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 2.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

Review 3.  Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.

Authors:  J Vaquero; T H Nguyen Ho-Bouldoires; A Clapéron; L Fouassier
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

4.  PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.

Authors:  Ning Li; Junfang Qin; Lan Lan; Hongyao Zhang; Fang Liu; Zhaozhen Wu; Hong Ni; Yue Wang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation.

Authors:  Kazutaka Ueda; Qing Lu; Wendy Baur; Mark J Aronovitz; Richard H Karas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-06       Impact factor: 8.311

6.  Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.

Authors:  Duiping Feng; Ying Xiong; Zhiqiang Peng; Qiang Ma; Tao Tao; Hua Liu; Jianfang Liang; Zhigang Wei; Junfang Zheng; Lei Wang; Hui Zhang
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

7.  EBP50 phosphorylation by Cdc2/Cyclin B kinase affects actin cytoskeleton reorganization and regulates functions of human breast cancer cell line MDA-MB-231.

Authors:  Chaoyuan Sun; Junfang Zheng; Shan Cheng; Duiping Feng; Junqi He
Journal:  Mol Cells       Date:  2013-06-14       Impact factor: 5.034

8.  In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.

Authors:  F Darío Cuello-Carrión; Niubys Cayado-Gutiérrez; Anthony L Natoli; Christina Restall; Robin L Anderson; Silvina Nadin; Daiana Alvarez-Olmedo; Gisela N Castro; Francisco E Gago; Mariel A Fanelli; Daniel R Ciocca
Journal:  Cell Stress Chaperones       Date:  2013-02-09       Impact factor: 3.667

9.  Involvement of estrogen receptor β5 in the progression of glioma.

Authors:  Wenjun Li; Ali Winters; Ethan Poteet; Myoung-Gwi Ryou; Song Lin; Shuyu Hao; Zhen Wu; Fang Yuan; Kimmo J Hatanpaa; James W Simpkins; Shao-Hua Yang
Journal:  Brain Res       Date:  2013-02-08       Impact factor: 3.252

Review 10.  The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.

Authors:  Sara Menazza; Elizabeth Murphy
Journal:  Circ Res       Date:  2016-01-07       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.